Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer-Reference-Cited by-同舟云学术

Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer

Published:2001-11 Issue:11 Volume:12 Page:1553-1559
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fogli S.,Danesi R.,De Braud F.,De Pas T.,Curigliano G.,Giovannetti E.,Del Tacca M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/12/11/1553/19478903/12-11-1553.pdf

Reference28 articles.

1. Future directions in non-small-cell lung cancer;Schiller;Semin Oncol,1999

2. Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small-cell lung cancer;Socinski;Semin Oncol,1999

3. Superiority of sequential vs concurrent administration of paclitaxel with etoposide in advanced non-small-cell lung cancer Comparison of two phase II trials;Felip;Clin Cancer Res,1998

4. A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small-cell lung cancer;Rosell;Semin Oncol,1997

5. The taxoids Comparative clinical pharmacology and therapeutic potential;Eisenhauer;Drugs,1998

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction Model for Severe Thrombocytopenia Induced by Gemcitabine Plus Cisplatin Combination Therapy in Patients with Urothelial Cancer;Clinical Drug Investigation;2024-04-29

2. Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development;Clinical Pharmacology & Therapeutics;2023-07-21

3. In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria;Antibiotics;2022-02-22

A NAG-Guided Nano-Delivery System for Redox- and pH-Triggered Intracellularly Sequential Drug Release in Cancer Cells

;International Journal of Nanomedicine;2020-02

5. Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia;Int. Journal of Clinical Pharmacology and Therapeutics;2018-07-01